Patent · US Active

Anti-CD38 antibodies

US12209138B2 · kind B2 · utility

0Cited by

24References

17Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Kathleen Ann Elias · San Francisco, US
Gregory Landes · San Bruno, US
Shweta Singh · Fremont, US
Wouter Korver · South San Francisco, US
Andrew W. Drake · Mountain View, US
Mary Haak-Frendscho · Madison, US
Gyorgy Pal Snell · South San Francisco, US
Vinay Bhaskar · South San Francisco, US

Key dates

Filing date	Aug 31, 2022
Grant date	Jan 28, 2025
Priority date	—
Expiry date	Oct 13, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.